Gilead Sciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6.96B | 7.92B | 7.77B | 7.08B | 6.67B | 7.57B | 7.54B | 6.95B |
| Cost of Goods Sold | 1.45B | 1.62B | 1.57B | 1.50B | 1.54B | 1.58B | 1.57B | 1.54B |
| Gross Profit | 5.51B | 6.30B | 6.20B | 5.58B | 5.13B | 5.99B | 5.97B | 5.41B |
| R&D Expenses | 1.37B | 1.58B | 1.35B | 1.49B | 1.38B | 1.64B | 1.40B | 1.35B |
| Operating Expenses | 2.93B | 3.31B | 2.87B | 3.11B | 2.89B | 3.54B | 5.08B | 2.77B |
| Operating Income | 2.59B | 2.99B | 3.33B | 2.47B | 2.24B | 2.45B | 888.0M | 2.64B |
| Other Income / Gains | -6.0M | -910.0M | 314.0M | -45.0M | -588.0M | -285.0M | 68.0M | -591.0M |
| Net Income | 2.02B | 2.18B | 3.05B | 1.96B | 1.31B | 1.78B | 1.25B | 1.61B |
| EPS (Diluted) | 1.63 | 1.76 | 2.46 | 1.57 | 1.06 | 1.43 | 1.00 | 1.29 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.792 | 0.795 | 0.798 | 0.788 | 0.769 | 0.791 | 0.791 | 0.778 |
| General And Administrative Expenses | 553.0M | 652.0M | 528.0M | 501.0M | 505.0M | 992.0M | 442.0M | 572.0M |
| Selling And Marketing Expenses | 898.0M | 1.08B | 829.0M | 864.0M | 753.0M | 869.0M | 968.0M | 805.0M |
| Selling General And Administrative Expenses | 1.45B | 1.73B | 1.36B | 1.36B | 1.26B | 1.86B | 1.41B | 1.38B |
| Other Expenses | 106.0M | 0 | 170.0M | 250.0M | 253.0M | 34.0M | 2.28B | 37.0M |
| Cost And Expenses | 4.37B | 4.94B | 4.44B | 4.61B | 4.43B | 5.12B | 6.66B | 4.31B |
| Interest Income | 0 | 95.0M | 88.0M | 73.0M | 94.0M | 85.0M | 52.0M | 35.0M |
| Interest Expense | 240.0M | 255.0M | 256.0M | 254.0M | 260.0M | 249.0M | 238.0M | 237.0M |
| Depreciation And Amortization | 0 | 687.0M | 686.0M | 691.0M | 696.0M | 693.0M | 690.0M | 694.0M |
| Ebitda | 2.35B | 3.02B | 4.58B | 3.37B | 2.60B | 3.11B | 1.88B | 2.98B |
| Ebitdaratio | 0.338 | 0.381 | 0.59 | 0.476 | 0.391 | 0.411 | 0.25 | 0.429 |
| Operating Income Ratio | 0.372 | 0.377 | 0.428 | 0.349 | 0.336 | 0.324 | 0.118 | 0.38 |
| Income Before Tax | 2.58B | 2.08B | 3.64B | 2.43B | 1.65B | 2.17B | 956.0M | 2.05B |
| Income Before Tax Ratio | 0.371 | 0.262 | 0.469 | 0.343 | 0.247 | 0.286 | 0.127 | 0.295 |
| Income Tax Expense | 559.0M | -105.0M | 589.0M | 468.0M | 334.0M | 385.0M | -297.0M | 438.0M |
| Net Income Ratio | 0.29 | 0.275 | 0.393 | 0.277 | 0.197 | 0.236 | 0.166 | 0.232 |
| Epsdiluted | 1.61 | 1.74 | 2.43 | 1.56 | 1.04 | 1.42 | 1.00 | 1.29 |
| Weighted Average Shs Out | 1.24B | 1.24B | 1.24B | 1.25B | 1.25B | 1.25B | 1.25B | 1.25B |
| Weighted Average Shs Out Dil | 1.25B | 1.25B | 1.25B | 1.25B | 1.26B | 1.26B | 1.25B | 1.25B |